May 5, 2025

Trump threatens 25% tariff; IPA reminds that India delivers 47% of America’s generic drug needs.

Trump Proposes 25% Tariff on Auto, Pharma, and Semiconductor Imports: Implications for India United States President Donald Trump has

The US FDA has approved a new Johnson & Johnson medication for an immune-related condition.

Johnson & Johnson Gains FDA Nod for New Immune Disorder Drug ‘Imaavy’ Healthcare leader Johnson & Johnson announced on

At Medipreneurx, our mission is to be the go-to online platform for healthcare professionals, providing customized resources to illuminate your path to success.

May 5, 2025

Trump threatens 25% tariff; IPA reminds that India delivers 47% of America’s generic drug needs.

The US FDA has approved a new Johnson & Johnson medication for an immune-related condition.

Important Links

Contact Info